Journal of Clinical Endocrinology & Metabolism, Vol 74, 1325-1330, Copyright © 1992 by Endocrine Society

ARTICLES

Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans

TD Geracioti Jr, DN Orth, NN Ekhator, B Blumenkopf and PT Loosen
Department of Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee 37232.

CRH, a hypothalamic peptide that is the most potent ACTH secretagogue known, also appears to be produced in the cerebral cortex and spinal cord. Depressed patients have blunted responses to exogenous CRH and normal to high concentrations of CRH immunoreactivity in single morning samples of lumbar cerebrospinal fluid (CSF). Although these data suggest that depression may be associated with hypersecretion of CRH, it has also been postulated that central nervous system insufficiency of CRH might have a pathophysiological role in certain depressive syndromes. We continuously sampled lumbar CSF via indwelling subarachnoid catheters from 1100-1700 h and measured CRH at 10-min intervals in depressed patients and normal subjects. A standardized mixed liquid meal was administered at 1300 h. CSF CRH was strikingly reduced in depressed patients compared to normal subjects [4.2 +/- 1.1 pmol/L vs. 13 +/- 2.1 pmol/L (mean +/- SEM), respectively, P less than 0.01 by Wilcoxon test]. CSF CRH concentrations rose progressively during the experiment in both groups, suggesting a diurnal rhythm and, possibly, response to a test meal. CRH had a very brief half-life in CSF (less than 10 min), suggesting that the spinal cord is the origin of CRH in lumbar CSF. The rapid transients in CSF CRH concentration demonstrate that single samples provide very limited information. There were no intraindividual correlations between CSF CRH concentrations and those of either plasma ACTH or cortisol, both of which rose in response to eating. The present data show that impaired central nervous system secretion of CRH can exist during states of severe depression.

This article has been cited by other articles:

				T. D. Geracioti Jr., L. L. Carpenter, M. J. Owens, D. G. Baker, N. N. Ekhator, P. S. Horn, J. R. Strawn, G. Sanacora, B. Kinkead, L. H. Price, et al. Elevated Cerebrospinal Fluid Substance P Concentrations in Posttraumatic Stress Disorder and Major Depression Am J Psychiatry, April 1, 2006; 163(4): 637 - 643. [Abstract] [Full Text] [PDF]

				D. G. Baker, N. N. Ekhator, J. W. Kasckow, B. Dashevsky, P. S. Horn, L. Bednarik, and T. D. Geracioti Jr. Higher Levels of Basal Serial CSF Cortisol in Combat Veterans With Posttraumatic Stress Disorder Am J Psychiatry, May 1, 2005; 162(5): 992 - 994. [Abstract] [Full Text] [PDF]

				M A Poca, M Mataro, J Sahuquillo, R Catalan, J Ibanez, and R Galard Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus J. Neurol. Neurosurg. Psychiatry, March 1, 2001; 70(3): 298 - 304. [Abstract] [Full Text] [PDF]

				M. Vythilingam, G. M. Anderson, M. J. Owens, T. M. Halaszynski, J. D. Bremner, L. L. Carpenter, G. R. Heninger, C. B. Nemeroff, and D. S. Charney Cerebrospinal Fluid Corticotropin-Releasing Hormone in Healthy Humans: Effects of Yohimbine and Naloxone J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4138 - 4145. [Abstract] [Full Text]

				D. G. Baker, S. A. West, W. E. Nicholson, N. N. Ekhator, J. W. Kasckow, K. K. Hill, A. B. Bruce, D. N. Orth, and T. D. Geracioti Jr. Serial CSF Corticotropin-Releasing Hormone Levels and Adrenocortical Activity in Combat Veterans With Posttraumatic Stress Disorder Am J Psychiatry, April 1, 1999; 156(4): 585 - 588. [Abstract] [Full Text]

				T. D. Geracioti Jr., S. A. West, D. G. Baker, K. K. Hill, N. N. Ekhator, M. D. Wortman, P. E. Keck Jr., and A. B. Norman Low CSF Concentration of a Dopamine Metabolite in Tobacco Smokers Am J Psychiatry, January 1, 1999; 156(1): 130 - 132. [Abstract] [Full Text]

				J. M. Martins, W. A. Banks, and A. J. Kastin Transport of CRH from mouse brain directly affects peripheral production of beta -endorphin by the spleen Am J Physiol Endocrinol Metab, December 1, 1997; 273(6): E1083 - E1089. [Abstract] [Full Text] [PDF]

				J. W. Kasckow, A. Regmi, P. S. Gill, D. G. Parkes, and T. D. Geracioti Regulation of Corticotropin-Releasing Factor (CRF) Messenger Ribonucleic Acid and CRF Peptide in the Amygdala: Studies in Primary Amygdalar Cultures Endocrinology, November 1, 1997; 138(11): 4774 - 4782. [Abstract] [Full Text] [PDF]

				L. D. Dorn, E. S. Burgess, T. C. Friedman, B. Dubbert, P. W. Gold, and G. P. Chrousos The Longitudinal Course of Psychopathology in Cushing's Syndrome after Correction of Hypercortisolism J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 912 - 919. [Abstract] [Full Text] [PDF]